Cutaneous Tumor Samples
Cutaneous Tumor Samples - Related Videos
11:35
Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
0 Views •
Cited by 16 •
2010
A dual-mode imaging system was developed for non-contact assessment of cutaneous tissue oxygenation and vascular function.
04:23
Frozen Skin Tissue Block Preparation: A Protocol to Preserve Cutaneous Melanoma Samples from Murine Dorsal Skin
0 Views •
2023
This video describes the detailed protocol for isolating melanoma-containing murine dorsal skin, followed by cryo-embedding to prepare a frozen skin tissue block. The cryo-embedded tissue block can be sectioned and microscopically examined to study melanoma progression.
06:44
Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
0 Views •
Cited by 22 •
2009
A demonstration of the bedside test for cutaneous allodynia and its clinical implications.
11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
0 Views •
Cited by 40 •
2012
Optimization of the experimental hamster model for cutaneous leishmaniasis by intradermal injection of Leishmania promastigotes at the dorsal skin. This approach is useful during inoculation, follow-up, characterization of lesions, application of treatments and obtaining of clinical samples. Locomotion, search for food and water, play and social activities are preserved.
07:32
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
0 Views •
Cited by 36 •
2012
Circulating tumor cells are isolated from the blood of cancer patients without inflicting cellular damage. Isolation of tumor cells is accomplished using a bimolecular surface of E-selectin in addition to antibodies against epithelial markers. A nanotube coating specifically promotes cancer cell adhesion resulting in high capture purities.
FAQs
Preservation maintains the specimen in a condition suitable for subsequent examination. Depending on the intended evaluation, the tissue may be fixed or preserved by another method before processing. This step supports the later assessment of architecture, cellular morphology, molecular features, and immunohistochemical characteristics, helping ensure that the sample remains useful for both clinical interpretation and research analysis.
Assessment combines several levels of information rather than relying on one feature. Tissue architecture shows how cells are organized, while cellular morphology describes their microscopic appearance. Molecular and immunohistochemical findings add further characterization. Together, these observations help differentiate tumor types and connect microscopic patterns with diagnostic evaluation in dermatologic medicine.
Microscopic examination evaluates tissue organization and cell appearance, whereas molecular and immunohistochemical analyses provide additional feature sets for characterizing the lesion. Considering these findings together can strengthen tumor classification and biomarker comparison. This combined approach is especially valuable when medical evaluation requires more than the architectural and morphological information visible in tissue sections.
The workflow begins with obtaining tissue from the skin neoplasm, followed by fixation or another preservation method. The specimen is then processed into sections for examination. Investigators or clinicians assess tissue architecture and cellular morphology, and may also evaluate molecular or immunohistochemical features. Each stage prepares the material for diagnostic or research interpretation.
In clinical medicine, findings from these specimens help confirm a diagnosis and assess characteristics of the tumor. Those results can contribute to management decisions by linking the lesion’s microscopic and other evaluated features with patient care. The samples therefore serve as an important connection between dermatologic pathology findings and clinical decision-making.
These specimens provide material for investigating how tumors develop, comparing biomarkers, and evaluating potential therapies. Researchers can relate tissue architecture and cellular morphology to molecular or immunohistochemical findings, creating a basis for comparing tumor characteristics across studies. This supports translational research that connects laboratory observations with advances in dermatologic oncology.